Take Your Partners, Please — Signal Diversification by the erbB Family of Receptor Tyrosine Kinases

References

• Alimandi M., Wang L.-M., Bottaro D., Lee C. C., Kuo A., Frankel M., Fedi P., Tang C., Lippman M., Pierce J. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors. EMBO J. 1997; 16: 5608–5617
   PubMed Web of Science ®Google Scholar
• Barbacci E., Guarino B., Stroh J., Singleton D., Rosnack K., Moyer J., Andrews G. The structural basis for the specificity of epidermal growth factor and heregulin binding. J. Biol. Chem. 1995; 270: 9585–9589
   PubMed Web of Science ®Google Scholar
• Batzer A. G., Blaikie P., Nelson K., Schlessinger J., Margolis B. The phosphotyrosine interaction domain of She binds an LXNPXY motif on the epidermal growth factor receptor. Mol. Cell. Biol. 1995; 15: 4403–4409
   PubMedGoogle Scholar
• Batzer A. G., Rotin D., Urena J. M., Skolnik E. Y., Schlessinger J. Hierarchy of binding sites for Grb2 and She on the epidermal growth factor receptor. Mol. Cell. Biol. 1994; 14: 5192–5201
   PubMed Web of Science ®Google Scholar
• Baulida J., Kraus M., Alimandi M., Di Fiore P., Carpenter G. All erbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J. Biol. Chem. 1996; 271: 5251–5257
   PubMed Web of Science ®Google Scholar
• Beerli R., Hynes N. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J. Biol. Chem. 1996; 271: 6071–6076
   PubMed Web of Science ®Google Scholar
• Busfield S., Michnick D., Chickering T., Revett T., Ma J., Woolf E., Comrack C., Dussault B., Woolf J., Goodearl A., Gearing D. Characterization of a neuregulin-related gene, Don-1, that is highly expressed in restricted regions of the cerebellum and hippocampus. Mol. Cell. Biol. 1997; 17: 4007–4014
   PubMedGoogle Scholar
• Carraway K., Weber J., Unger M., Ledesma J., Yu N., Gassman M., Lai C. Neuregulin-2, a new ligand of ErbB3. ErbB4-receptor tyrosine kinases. Nature 1997; 387: 512–516
   PubMed Web of Science ®Google Scholar
• Carraway K. L., III, Sliwkowski M. X., Akita R., Platko J. V., Guy P. M., Nuijens A., Diamonti A. J., Vandlen R. L., Cantley L. C., Cerione R. A. The erbB3 gene product is a receptor for heregulin. J. Biol. Chem. 1994; 269: 14303–14306
   PubMed Web of Science ®Google Scholar
• Chang H., Riese I I, Gilbert W. D., Stern D., McMahan U. Ligands for ErbB-family receptors encoded by a neuregulin-like gene. Nature 1997; 387: 509–512
   PubMed Web of Science ®Google Scholar
• Cohen B., Green J., Foy L., Fell H. HER4-mediated biological and biochemical properties in NIH-3T3 cells. J. Biol. Chem. 1996; 271: 4813–4818
   PubMedGoogle Scholar
• Crovello C., Lai C., Cantley L., Carraway K., III. Differential signaling by the epidermal growth factor-like growth factors neuregulin-1 and neuregulin-2. J. Biol. Chem. 1998; 273: 26954–26961
   PubMedGoogle Scholar
• Di Fiore P. P., Pierce J. H., Kraus M. H., Segatto O., King C. R., Aaronson S. A. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 1987; 237: 178–182
   PubMed Web of Science ®Google Scholar
• Elenius K., Paul S., Allison G., Sun J., Klagsbrun M. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J. 1997; 16: 1268–1278
   PubMedGoogle Scholar
• Fazioli F., Kim U., Rhee S., Molloy C., Segatto O., Di Fiore P. The erbB-2 mitogenic signalling pathway: tyrosine phosphorylation of phospholipase C-γ and GTPase-activating protein does not correlate with erbB-2 mitogenic potency. Mol. Cell. Biol. 1991; 11: 2040–2048
   PubMed Web of Science ®Google Scholar
• Fcdi P., Pierce J. H., DiFiore P. P., Kraus M. H. Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase Cγ or GTPase activating protein, distinguishes erbB-3 signaling from that of other erbB: EGFR family members. Mol. Cell. Biol. 1994; 14: 492–500
   Google Scholar
• Fiddes R. J., Campbell D. H., Janes P. W., Sivertsen S. P., Sasaki H., Wallasch C., Daly R. J. Analysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3. J. Biol. Chem. 1998; 273: 7717–7724
   PubMedGoogle Scholar
• Fiddes R. J., Janes P. W., Sanderson G. M., Sivertsen S. P., Sutherland R. L., Daly R. J. Heregulin (HRG)-induced mitogenic signaling and cytotoxic activity of a HRG PE40 ligand toxin in human breast cancer cells. Cell Growth Differ. 1995; 6: 1567–1577
   PubMedGoogle Scholar
• Gassman M., Casagranda F., Orioli D., Simon H., Lai C., Klein R., Lemke G. Aberrant neural and cardiac development in mice lacking the erbB4 neuregulin receptor. Nature 1995; 378: 390–394
   PubMedGoogle Scholar
• Graus-Porta D., Beerli R. R., Daly J. M., Hynes N. E. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J. 1997; 16: 1647–1655
   PubMed Web of Science ®Google Scholar
• Guy P. M., Platko J. V., Cantley L. C., Cerione R. A., Carraway K. L. Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. Proc. Natl. Acad. Sci. USA 1994; 91: 8132–8136
   PubMed Web of Science ®Google Scholar
• Holgado-Madruga M., Emlet D., Moscatello D., Godwin A., Wong A. A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 1996; 379: 560–564
   PubMed Web of Science ®Google Scholar
• Holmes W. E., Sliwkowski M. X., Akita R. W., Hcnzel W. J., Lee J., Park J. W., Yansura D., Abadi N., Raab H., Lewis C. D., Shepard H. M., Kuang W. J., Wood W. I., Goeddel D. V., Vandlen R. L. Identification of heregulin, a specific activator of p185erbB-2. Science 1992; 256: 1205–1210
   PubMed Web of Science ®Google Scholar
• Hu P., Margolis B., Skolnik E. Y., Lammers R., Ullrich A., Schlessinger J. Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors. Mol. Cell. Biol. 1992; 12: 981–990
   PubMed Web of Science ®Google Scholar
• Jacobsen N., Abadi N., Sliwkowski M., Reilly D., Skelton N., Fairbrother W. High-resolution solution structure of the EGF-like domain of heregulin-alpha. Biochemistry 1996; 35: 3402–3417
   PubMedGoogle Scholar
• Janes P. W., Daly R. J., deFazio A., Sutherland R. L. Activation of the Ras signalling pathway in human breast cancer cell lines overexpressing erbB-2. Oncogene 1994; 9: 3601–3608
   PubMed Web of Science ®Google Scholar
• Karunagaran D., Tzahar E., Beerli R., Chen X., Graus-Porta D., Ratzkin B., Seger R., Hynes N., Yarden Y. ErbB2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J. 1996; 15: 254–264
   PubMed Web of Science ®Google Scholar
• Kim H. H., Sierke S. L., Koland J. G. Epidermal growth factor-dependent association of phosphatidyl 3-kinase with the erbH3 gene product. J. Biol. Chem. 1994; 269: 24747–24755
   PubMed Web of Science ®Google Scholar
• King C. R., Borrello I., Bellot F., Comoglio P., Schlessinger J. EGF binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3. EMBO J. 1988; 7: 1647–1651
   PubMed Web of Science ®Google Scholar
• Komurasaki T., Toyoda H., Uchida D., Morimoto S. Epiregulin binds to epidermal growth factor receptor and ErbB4 and induces tyrosine phosphorylation of epidermal growth factor receptor. ErbB2, ErbB3 and ErbB4. Oncogene 1997; 15: 2841–2848
   PubMedGoogle Scholar
• Lee K. F., Simon H., Chen H., Bates B., Hung M. C., Hauser C. Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 1995; 378: 394–398
   PubMed Web of Science ®Google Scholar
• Lenferink A., Pinkas-Kramarski R., van de Poll M., van Vugt M., Klapper L., Tzahar E., Waterman H., Sela M., van Zoelen E., Yarden Y. Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers. EMBO J. 1998; 17: 3385–3397
   PubMed Web of Science ®Google Scholar
• Levkowitz G., Klapper L. N., Tzahar E., Freywald A., Sela M., Yarden Y. Coupling of the c-Cbl proto-oncogene to erbB-1/EGF-receptor but not to other erbB proteins. Oncogene 1996; 12: 1117–1125
   PubMedGoogle Scholar
• Lonardo F., Di Marco E., King C. R., Pierce J. H., Segatto O., Aaronson S. A., Di Fiore P. P. The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand. New Biol. 1990; 2: 992–1003
   PubMedGoogle Scholar
• Lowenstein E. J., Daly R. J., Batzer A. G., Li W., Margolis B., Lammers R., Ullrich A., Skolnik E. Y., Bar-Sagi D., Schlessinger J. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signalling. Cell 1992; 70: 431–442
   PubMed Web of Science ®Google Scholar
• Luttrell D. K., Lee A., Lansing T. J., Crosby R. M., Jung K. D., Willard D., Luther M., Rodriguez M., Berman J., Gilmer T. M. Involvement of pp60c-src with two major signalling pathways in human breast cancer. Proc. Natl. Acad. Sci. USA 1994; 91: 83–87
   PubMed Web of Science ®Google Scholar
• Margolis B., Rhee S. G., Felder S., Mervic M., Lyall R., Levitzki A., Ullrich A., Zilberstein A., Schlessinger J. EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling. Cell 1989; 57: 1101–1107
   PubMed Web of Science ®Google Scholar
• Margolis B., Silvennoinen O., Comoglio F., Roonprapunt C., Skolnik E., Ullrich A., Schlessinger J. High-efficiency expression/cloning of epidermal growth factor receptor-binding proteins with src homology 2 domains. Proc. Natl. Acad. Sci. USA 1992; 89: 8894–8898
   PubMedGoogle Scholar
• Massague J. Transforming growth factor-α, a model for membrane-anchored growth factors. J. Biol. Chem. 1990; 265: 21393–21396
   PubMed Web of Science ®Google Scholar
• Mc Innes C., Sykes B. Growth factor receptors: structure, mechanism and drug discovery. Biopolymers 1998; 43: 339–366
   Google Scholar
• Muthuswamy S., Muller W. Direct and specific interaction of c-Src with Neu is involved in signaling by the epidermal growth factor receptor. Oncogene 1995; 11: 271–279
   PubMed Web of Science ®Google Scholar
• Nagata K., Kohda D., Hatanaka H., Ichikawa S., Matsuda S., Yamamoto T., Suzuki A., Inagaki F. Solution structure of the epidermal growth factor-like domain of heregulin-alpha, a ligand for p180erbB-4. EMBO J. 1994; 13: 3517–3523
   Google Scholar
• Olayioye M., Graus-Porta D., Beerli R., Rohrer J., Gay B., Hynes N. EerbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner. Mol. Cell. Biol. 1998; 18: 5042–5051
   PubMed Web of Science ®Google Scholar
• Peles E., Levy R., Or E., Ullrich A., Yarden Y. Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase Cγ. EMBO J. 1991; 10: 2077–2086
   PubMed Web of Science ®Google Scholar
• Pinkas-Kramarski R., Alroy I., Yarden Y. ErbB receptors and EGF-like ligands: cell lineage determination and oncogenesis through combinatorial signaling. J. Mammary Gland Biol. Neoplasia 1997; 2: 97–107
   PubMed Web of Science ®Google Scholar
• Pinkas-Kramarski R., Lenferink A., Bacus S., Lyass L., van de Poll M., Klapper L., Tzahar E., Sela M., van Zoelen E., Yarden Y. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin. Oncogene 1998a; 16: 1249–1258
   PubMed Web of Science ®Google Scholar
• Pinkas-Kramarski R., Shelly M., Glathe S., Ratzkin B., Yarden Y. Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations. J. Biol. Chem. 1996; 271: 19029–19032
   PubMed Web of Science ®Google Scholar
• Pinkas-Kramarski R., Shelly M., Guarino B., Wang L., Lyass L., Alroy I., Alamandi M., Kuo A., Moyer J., Lavi S., Eisenstein M., Ratzkin B., Seger R., Bacus S., Pierce J., Andrews G., Yarden Y. ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network. Mol. Cell. Biol. 1998b; 18: 6090–6101
   PubMed Web of Science ®Google Scholar
• Plowman G. D., Green J. M., Culouscou J. M., Carlton G. W., Rothwell V. M., Buckley S. Heregulin induces tyrosine phosphorylation of HER4/p180erbB4. Nature 1993; 366: 473–475
   PubMed Web of Science ®Google Scholar
• Prigent S. A., Gullick W. J. Identification of c-erbB-3 binding sites for phosphatidylinositol 3-kinase and SHC using an EGF receptor/c-erbB-3 chimera. EMBO J. 1994; 13: 2831–2841
   PubMed Web of Science ®Google Scholar
• Ricci A., Lanfrancone L., Chiari R., Belardo G., Pertica C., Natali P. G., Pelicci P. G., Segatto O. Analysis of protein-protein interactions involved in the activation of the Shc/Grb2 pathway by the erbB-2 kinase. Oncogene 1995; 11: 1519–1529
   PubMedGoogle Scholar
• Riese D., II, van Raaij T., Plowman G., Andrews G., Stern D. The cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Mol. Cell. Biol. 1995; 15: 5770–5776
   PubMed Web of Science ®Google Scholar
• Riese D. J., II, Bermingham Y., van Raaij T. M., Buckley S., Plowman G. D., Stern D. F. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-ß. Oncogene 1996; 12: 345–353
   PubMed Web of Science ®Google Scholar
• Riethmacher D., Sonnenberg-Riethmacher E., Brinkmann V., Yamaai T., Lewin G., Birchmeier C. Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature 1997; 389: 725–729
   PubMed Web of Science ®Google Scholar
• Sepp-Lorenzino L., Eberhard I., Ma Z., Cho C., Serve H., Liu F., Rosen N., Lupu R. Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells. Oncogene 1996; 12: 1679–1687
   PubMedGoogle Scholar
• Sibilia M., Wagner E. Strain-dependent epithelial defects in mice lacking EGF receptor. Science 1995; 269: 234–238
   PubMed Web of Science ®Google Scholar
• Slamon D. J., Godolphin W., Jones L. A., Holt J. A., Wong S. G., Keith D. E., Levin W. J., Stuart S. G., Udove J., Ullrich A., Press M. F. Studies of the HER2/neu proto-oncogene in human breast and ovarian cancer. Science 1989; 244: 707–712
   PubMed Web of Science ®Google Scholar
• Sliwkowski M. X., Schaefer G., Akita R. W., Lofgren J. A., Fitzpatrick V. D., Nuijens A., Fendly B. M., Cerione R. A., Vandlen R. L., Carraway K. L. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J. Biol. Chem. 1994; 269: 14661–14665
   PubMed Web of Science ®Google Scholar
• Soltoff S. P., Carraway K. L., Prigent S. A., Gullick W. G., Cantley L. C. ErbB3 is involved in activation of phosphatidyl 3-kinase by epidermal growth factor. Mol. Cell. Biol. 1994; 14: 3550–3558
   PubMed Web of Science ®Google Scholar
• Stover D., Becker M., Liebetanz J., Lydon N. Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with Src and p85α. J. Biol. Chem. 1995; 270: 15591–15597
   PubMed Web of Science ®Google Scholar
• Threadgill D., Dlugosz A., Hansen L., Tennenbaum T., Lichti U., Yee D., La-Mantia C., Mourton T., Herrup K., Harris R., Barnard J., Yuspa S., Coffey R., Magnuson T. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 1995; 269: 230–234
   PubMed Web of Science ®Google Scholar
• Tzahar E., Levkowitz G., Karunagaran D., Yi L., Peles E., Lavi S., Chang D., Liu N., Yayon A., Wen D., Yarden Y. ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all neu differentiation factor/heregulin isoforms. J. Biol. Chem. 1994; 269: 25226–25233
   PubMed Web of Science ®Google Scholar
• Tzahar E., Pinkas-Kramarski R., Moyer J., Klapper L., Alroy I., Levkowitz G., Shelly M., Henis S., Eisenstein S., Ratzkin B., Sela M., Andrews G., Yarden Y. Bivalence of EGF-like ligands drives the ErbB signaling network. EMBO J. 1997; 16: 4938–4950
   PubMed Web of Science ®Google Scholar
• Tzahar E., Waterman H., Chen X., Levkowitz G., Karunagaran D., Lavi S., Ratzkin B., Yarden Y. A hierarchical network of interreceptor interactions determines signal transduction by neu differentiation factor neuregulin and epidermal growth factor. Mol. Cell. Biol. 1996; 16: 5276–5287
   PubMed Web of Science ®Google Scholar
• Wada T., Qian X., Greene M. I. Intermolecular association of p185neu protein and EGF receptor modulates EGF receptor function. Cell 1990; 61: 1339–1347
   PubMed Web of Science ®Google Scholar
• Wallasch C., Weiss F., Niederfellner G., Jallal B., Issing W., Ullrich A. Heregulin-dependent regulation of HER2 neu oncogenic signaling by heterodimerization with HER3. EMBO J. 1995; 14: 4267–4275
   PubMed Web of Science ®Google Scholar
• Wen D., Peles E., Cupples R., Suggs S. V., Bacus S. S., Luo Y., Trail G., Hu S., Silbiger S. M., Levy R. B., BenLevy R., Koski R. A., Lu H. S., Yarden Y. Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell 1992; 69: 559–572
   PubMed Web of Science ®Google Scholar
• Wong A., Ruppert J., Bigner S., Grzeschik C., Humphrey P., Bigner D., Vogelstein B. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc. Natl. Acad. Sci (USA) 1992; 89: 2965–2969
   PubMed Web of Science ®Google Scholar
• Zhang D., Sliwkowski M., Mark M., Frantz G., Akita R., Sun Y., Hillan K., Crowley C., Brush J., Godowski P. Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc. Natl. Acad. Sci (USA) 1997; 94: 9562–9567
   PubMed Web of Science ®Google Scholar
• Zhang K., Sun J., Liu N., Wen D., Chang D., Thomason A., Yoshinaga S. Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2. J. Biol. Chem. 1996; 271: 3884–3890
   PubMed Web of Science ®Google Scholar